Biogen Idec to consider purchase offers
Interest from Icahn may have prompted biotech's decision
Biogen Idec Inc., the state's largest biotech company, is up for sale. The Cambridge firm, worth more than $20 billion, said late yesterday it plans to consider outside offers, after receiving multiple "expressions of interest," including one from billionaire corporate raider Carl Icahn. (Full article: 886 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass
